NCT01570413

Brief Summary

This study is designed to determine whether the pelvic examination (including bimanual and speculum examination) is necessary in patients with first trimester vaginal bleeding/ lower abdominal pain when an intra-uterine pregnancy (IUP) is seen on ultrasound. Patients with the chief complaint of vaginal bleeding or lower abdominal pain less than 16 weeks and positive HCG will be considered for this non-inferiority-designed clinical trial. All patients who present to the BMC Emergency Department (ED) Mon - Fri from 8am to 11pm and have had serum or urine HCG testing and a formal ultrasound by a credentialed emergency physician or radiology technician as part of standard of care will be screened for further eligibility. Those patients with intra-uterine pregnancies \< 16 weeks gestation seen on ultrasound and meet inclusion criteria will then be asked to provide informed consent to participate in the study. Randomization will occur after consent has been obtained. Half of the patients will be randomized to receive pelvic examinations and the other half will not. Further care will be determined by the treating attending physician. The primary outcome will be a composite morbidity endpoint at 30 days, including return visits to the ED, emergency surgery, need for transfusion, infection, or other missed source of bleeding/ pain. Secondary outcomes of interest include ED throughput time, and patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 4, 2012

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

May 4, 2017

Status Verified

May 1, 2017

Enrollment Period

3.9 years

First QC Date

February 27, 2012

Last Update Submit

May 3, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite Morbidity Endpoint

    Adverse events include, but are not limited to, return visits to the Emergency Department, need for hospital admission, emergency procedure, transfusion, infection, or identification of other source of symptoms.

    30 Days

Secondary Outcomes (2)

  • Patient Satisfaction

    24 Hours

  • Throughput Time

    24 Hours

Study Arms (2)

Pelvic Exam

ACTIVE COMPARATOR

Subjects receive pelvic exam

Procedure: Pelvic Examination

No Pelvic Exam

EXPERIMENTAL

Subjects do not receive pelvic exam

Procedure: No Pelvic Exam

Interventions

Will not receive pelvic examination.

No Pelvic Exam

Pelvic examination will be performed.

Pelvic Exam

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chief complaint of vaginal bleeding or lower abdominal pain
  • Intra-uterine pregnancy seen on ultrasound
  • Date \< 16 weeks by estimated LMP or ultrasound
  • Age \>21
  • Ability to provide written informed consent
  • English speaking

You may not qualify if:

  • Already enrolled in study
  • Morbid Obesity (BMI \> 40)
  • Pelvic exam performed prior to ultrasound results
  • Prisoner
  • Follow up cannot be assured
  • Admitted to hospital
  • Large amount of vaginal bleeding (\>10 pads in 24 hours or equivalent)
  • Unstable vital signs (SBP\<90 or HR\>110)
  • Known cervical carcinoma in the past 1 year
  • Clinical suspicion for alternative syndrome that requires pelvic exam (such as severe pain consistent with ovarian torsion)
  • Report or suspicion of penetrating vaginal trauma
  • Suspicion of Active Labor
  • Reported Sexual Assault
  • Current pregnancy by IVF
  • IUD in place
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, United States

Location

Related Publications (5)

  • Brown J, Fleming R, Aristzabel J, Gishta R. Does pelvic exam in the emergency department add useful information? West J Emerg Med. 2011 May;12(2):208-12.

    PMID: 21691528BACKGROUND
  • Brown T, Herbert ME. Medical myth: Bimanual pelvic examination is a reliable decision aid in the investigation of acute abdominal pain or vaginal bleeding. CJEM. 2003 Mar;5(2):120-2. doi: 10.1017/s1481803500008289.

    PMID: 17475104BACKGROUND
  • Hoey R, Allan K. Does speculum examination have a role in assessing bleeding in early pregnancy? Emerg Med J. 2004 Jul;21(4):461-3. doi: 10.1136/emj.2003.012443.

    PMID: 15208231BACKGROUND
  • Isoardi K. Review article: the use of pelvic examination within the emergency department in the assessment of early pregnancy bleeding. Emerg Med Australas. 2009 Dec;21(6):440-8. doi: 10.1111/j.1742-6723.2009.01227.x.

    PMID: 20002713BACKGROUND
  • Seymour A, Abebe H, Pavlik D, Sacchetti A. Pelvic examination is unnecessary in pregnant patients with a normal bedside ultrasound. Am J Emerg Med. 2010 Feb;28(2):213-6. doi: 10.1016/j.ajem.2008.10.018.

    PMID: 20159393BACKGROUND

MeSH Terms

Conditions

Abdominal Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Officials

  • Judith Linden, MD

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
BMC Faculty

Study Record Dates

First Submitted

February 27, 2012

First Posted

April 4, 2012

Study Start

February 1, 2012

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

May 4, 2017

Record last verified: 2017-05

Locations